Zkusit zdarma
ICU Medical, Inc.

ICU Medical, Inc.

ICUI
Cena:
 
 
Valuace
8
Růst
30
Zdraví
58

Výsledky Q1 2026

Načítám obsah…
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide.
The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
preloader

Prezentace a earnings calls ICU Medical, Inc. (ICUI)

DatumNázevKvartálRok
07.05.2026ICUI Q1 2026Q12026
02.03.2026ICUI 47th Annual Raymond James Institutional Investor Conference--
19.02.2026ICUI Q4 2025Q42025
14.01.2026ICUI 44th Annual J.P. Morgan Healthcare Conference--
06.11.2025ICUI Q3 2025Q32025
04.09.2025ICUI Wells Fargo 20th Annual Healthcare Conference 2025--
07.08.2025ICUI Q2 2025Q22025
08.05.2025ICUI Q1 2025Q12025
07.04.2025ICUI 24th Annual Needham Virtual Healthcare Conference--
19.03.2025ICUI KeyBanc Annual Healthcare Forum 2025--